Hollnberger, J., Liu, Y., Xu, S., Chang, S., Martin, R., Manhas, S., . . . Urban, S. (2023). No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta. Journal of hepatology, 79(3), . https://doi.org/10.1016/j.jhep.2023.04.027
Chicago-Zitierstil (17. Ausg.)Hollnberger, Julius, et al. "No Virologic Resistance to Bulevirtide Monotherapy Detected in Patients Through 24 Weeks Treatment in Phase II and III Clinical Trials for Chronic Hepatitis Delta." Journal of Hepatology 79, no. 3 (2023). https://doi.org/10.1016/j.jhep.2023.04.027.
MLA-Zitierstil (9. Ausg.)Hollnberger, Julius, et al. "No Virologic Resistance to Bulevirtide Monotherapy Detected in Patients Through 24 Weeks Treatment in Phase II and III Clinical Trials for Chronic Hepatitis Delta." Journal of Hepatology, vol. 79, no. 3, 2023, https://doi.org/10.1016/j.jhep.2023.04.027.